Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2005-08-18
2009-02-03
Davis, Ruth A (Department: 1651)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S198100, C424S184100, C424S278100
Reexamination Certificate
active
07485298
ABSTRACT:
New methods for diagnosis and treatment of human dormancy syndrome-related sequellae are provided. Human dormancy syndrome (HDS) is characterized by elevated serum ratio of rT3/fT3 compared to a population of normal subjects. HDS includes fibromyalgia, chronic fatigue, cancer, autoimmune disease, obesity and related dormancy conditions. Dormancy and HDS-related sequellae are imposed on humans by infection with lipopolysaccharide (LPS; or endotoxin)-producing organisms, especially those that are intracellular and those that create antigens that stimulate the TLR pathways. In such instances, the elimination or neutralization of the LPS signal along with the infectious source is required to impact the sequellae of HDS. Treatment includes use of novel and non-obvious doses of antibiotics, optionally including agents that decrease the adverse effects of endotoxin.
REFERENCES:
patent: 5158978 (1992-10-01), Rubin
patent: 5342788 (1994-08-01), Kunst et al.
patent: 5691456 (1997-11-01), Adamczyk et al.
patent: 6087090 (2000-07-01), Mascarenhas
patent: 6579854 (2003-06-01), Mitchell et al.
patent: 6664239 (2003-12-01), Mitchell et al.
patent: 6756369 (2004-06-01), Mitchell et al.
patent: 2003/0007941 (2003-01-01), Cornelius et al.
patent: 2003/0228628 (2003-12-01), Powell
Marshall TG, Marshall FE;Sarcoidosis Succumbs to Antibiotics—Implication of Autoimmune Disease; Autoimmune Rev. Jun. 2004; 3(4); 295-300.
Hannah V. Carey,Physical Rev83; Mammalian Hibernation: Cellular and Molecular Responses to Depressed Metabolism and Low Temperature: pp. 1153-1181.
Borson D. Benjamin
Borson Law Group PC
Davis Ruth A
LandOfFree
Diagnosis and treatment of human dormancy-related sequellae does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis and treatment of human dormancy-related sequellae, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and treatment of human dormancy-related sequellae will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4120035